GenMark Diagnostics, Inc. (GNMK)

[biocqr]

GenMark Diagnostics announces public offering of $60 mln of shares of its common stock (9.72 -0.31)

J.P. Morgan Securities LLC will act as sole book-running manager for the proposed offering. The co intends to use the net proceeds from this offering for general corporate purposes, including, but not limited to, the acceleration of its test menu and NexGen platform development, the expansion of its domestic commercial team, the acceleration of its international expansion, increases in administrative infrastructure to support its international and domestic expansion, automation of its manufacturing infrastructure and other working capital requirements.


Read more: http://www.briefing.com/InPlayEq/InPlay/InPlayDual.htm#ixzz2bmzAqNXs
Under Creative Commons License: Attribution